The process of mRNA turnover is important in numerous aspects of eukaryotic mRNA physiology. These roles include the control of gene expression, antiviral defenses 1,2 and mRNA surveillance by recognizing and degrading the aberrant mRNAs 3 . Two major pathways of mRNA decay exist in eukaryotic cells 4 . In both yeast and mammals, mRNA degradation usually begins with the shortening of the poly(A) tail at the 3′ end of the mRNA. After deadenylation, the 5′ cap structure can be removed (decapping), thereby exposing the transcript to digestion by a 5′→3′ exonuclease Xrn1p 5-8 . Alternatively, after deadenylation in both yeast and mammals, mRNAs can be degraded in a 3′→5′ direction by the cytoplasmic exosome 9-12 . The resulting cap structure is hydrolyzed by the DcpS scavenger decapping enzyme, which is encoded by the DCS1 gene in yeast 13 .
The process of mRNA turnover is important in numerous aspects of eukaryotic mRNA physiology. These roles include the control of gene expression, antiviral defenses 1,2 and mRNA surveillance by recognizing and degrading the aberrant mRNAs 3 . Two major pathways of mRNA decay exist in eukaryotic cells 4 . In both yeast and mammals, mRNA degradation usually begins with the shortening of the poly(A) tail at the 3′ end of the mRNA. After deadenylation, the 5′ cap structure can be removed (decapping), thereby exposing the transcript to digestion by a 5′→3′ exonuclease Xrn1p [5] [6] [7] [8] . Alternatively, after deadenylation in both yeast and mammals, mRNAs can be degraded in a 3′→5′ direction by the cytoplasmic exosome [9] [10] [11] [12] . The resulting cap structure is hydrolyzed by the DcpS scavenger decapping enzyme, which is encoded by the DCS1 gene in yeast 13 .
Decapping is a key step in the 5′→3′ decay pathway because it induces degradation of the mRNA, and thus it is subject to numerous control inputs. Decapping is also critical in an aspect of mRNA surveillance in which aberrant mRNAs containing nonsense codons are decapped without a requirement for deadenylation and are degraded in a 5′→3′ direction [14] [15] [16] . Several observations suggest that Dcp1p and Dcp2p function together in vivo in a decapping holoenzyme with Dcp2p as the catalytic subunit. First, both Dcp1p and Dcp2p are required for decapping in vivo in yeast 17, 18 . Second, yeast and human Dcp1 and Dcp2 proteins physically interact with each other in vivo and in vitro [18] [19] [20] [21] . Evidence that Dcp2p is the catalytic subunit comes from the recent demonstration that recombinant yeast and human Dcp2 proteins have decapping activity [20] [21] [22] [23] . Dcp2p contains a Nudix motif, which is found in a class of pyrophosphatases 18, [23] [24] [25] , and mutations in the Dcp2p Nudix motif inactivate decapping activity in vivo and in vitro in both the yeast and mammalian enzymes 18, [20] [21] [22] [23] . Notably, recombinant human Dcp2 protein is a more robust enzyme than the yeast protein, which requires either manganese or high levels of magnesium to function [21] [22] [23] . Although recombinant Dcp1p has been reported to have decapping activity 26 , several groups have not detected such activity under a variety of conditions [20] [21] [22] . However, recombinant Dcp1p can clearly enhance the activity of yeast Dcp2p, allowing Dcp2p to decap efficiently under conditions in which it has little activity on its own 21 . The simplest interpretation of these observations is that Dcp2p is the catalytic subunit of the decapping complex, and Dcp1p primarily functions to enhance Dcp2p activity, although how Dcp1p does this is unknown. The Dcp1 protein is conserved in eukaryotes, and two human homologs, hDcp1a and hDcp1b, have been identified, with hDcp1a copurified with decapping activity 20 . Moreover, hDcp1a (also called SMIF) may have a role in SMAD-mediated TGFβ signaling because it interacts with Smad4 and partially translocates to the nucleus in response to transformation growth factor-β stimulation 27 .
To gain insight into the molecular mechanism of decapping carried out by Dcp1p and Dcp2p, we determined the crystal structure of yeast Dcp1p at a resolution of 2.3 Å. The overall fold of Dcp1p is markedly similar to that of EVH1/WH1 family of domains. Comparison of the PRS-binding sites in this family of proteins with Dcp1p indicates that Dcp1p belongs to a novel class of EVH1 domains. Mapping of the sequence conservation on the molecular surface reveals two prominent sites, one required for decapping activity and the other a possible regulatory site. Furthermore, we show that a conserved hydrophobic patch on the Dcp1p surface is critical for decapping.
RESULTS

Overall structure of Dcp1p
The crystal structure of Dcp1p was solved by single wavelength anomalous dispersion (SAD) using selenomethionine (SeMet)-substituted crystals. The final model contains two copies of the Dcp1p, designated as molecules A and B, respectively. Several regions of the polypeptide are not visible in the electron density map and are assumed to be disordered, namely residues 1-21, 74-134 and 229-231 for molecule A, and residues 1-16 and 81-134 for molecule B in the crystallographic asymmetric unit. The current refined model has an R-factor of 22.7% and a R free value of 26.8% at a resolution of 2.3 Å with very good stereochemistry (see Table 1 and Methods). m 7 GDP could not be located in the electron density map or in washed crystals, suggesting that m 7 GDP probably does not bind in the crystal lattice (data not shown).
No substantial differences are observed between the structures of the two Dcp1p molecules in the asymmetric unit (r.m.s. deviation of 0.60 Å for all the equivalent Cα atoms). Because molecule B is more complete than molecule A, all subsequent analyses reported here refer to the coordinates of the molecule B. Dcp1p is composed of three α-helices and seven β-strands. A notable feature of the tertiary structure is the formation of a β-sandwich by two antiparallel β-sheets (Fig. 1a) . A V-shaped concave groove is formed by the outside of β-strands 1, 2, 5, 6 and 7; another concave groove, which is opposite to the V-shaped groove, is formed by the N-terminal 3 10 -helix and β-strands 1-4. A long helix (α3) is located on one side of the β-sandwich with two short helices (α1 and α2) running across the top of the β-sandwich.
Dcp1p structurally resembles EVH1/WH1 domains
A search of the Protein Data Bank using the Dali server 28 indicated that Dcp1p belongs to a structural family of EVH1/WH1 domains including Mena 29 (PDB entry 1EVH; Z-score 12.9), and Ranbinding protein 30 (RanBP; PDB entry 1RRP; Z-score 11.4). Dcp1p markedly resembles the structures of the EVH1/WH1 domains ( Fig. 1) . Superposition of the equivalent Cα atoms of Dcp1p and other EVH1 domains gives rise to r.m.s. deviation values of 1.70 Å, 1.6 Å, 1.7 Å and 1.8 Å for Mena, Homer 31 (PDB entry 1DDV), N-WASP 32 (PDB entry 1MKE) and RanBP, respectively. The core regions for these structures are very similar. The best matches are found in the central β-sandwich, with the largest deviations in the C-terminal α-helix (α3). Consistent with this analysis, human Dcp1a/SMIF, which shares ∼17% identity with yeast Dcp1p in the N terminus (Fig. 2) , has been predicted to have an EVH1/WH1 domain at its N terminus 33 (Fig. 1f) . Despite the similarities, some structural differences exist between the Dcp1p structure and these related structures. The most notable differences are the two short helices, α1 and α2, which have no counterparts in the EVH1 domains of Mena, Homer, N-WASP and RanBP. Sequence comparison of Dcp1p with other eukaryotic Dcp1 proteins indicates that this region is a unique feature of yeast Dcp1p (Fig. 2) . The N-terminal extended peptide of Dcp1p is reminiscent of the N-terminal extension of RanBP, but such an N-terminal extension is nonexistent in other EVH1 domains (Fig. 1) . This N-terminal extension seems to be functionally important, because mutations in this region can affect decapping in vivo 34 . All known EVH1 domains consist of contiguous stretches of amino acids found at the N terminus 35 . In contrast, the EVH1 fold in yeast Dcp1p has an insert (residues 80-135) that is largely disordered in the structure. Because this insert is only present in the yeast Dcp1p (Fig. 2) , it is not likely to be central to Dcp1p function and is probably involved in yeast-specific functions.
Two patches as putative ligand-binding sites
Previous analyses of Dcp1p have indicated that this protein interacts with the mRNA substrate and several yeast proteins involved in decapping including Dcp2p, Dhh1p, Edc1p, Edc2p and Edc3p [17] [18] [19] [36] [37] [38] , although only in the case of Dcp2p is there clear evidence that the interaction is direct. To identify key domains on the surface of Dcp1p, we mapped the degree of amino acid conservation shared between Dcp1p and other eukaryotic Dcp1 sequences on the Dcp1p molecular surface. This analysis revealed two prominent regions of structural conservation, which we discuss below (Fig. 3a,b) .
One of the regions (designated as conserved patch 1) is situated in a concave V-shaped groove formed by β-strands 1, 2, 5, 6 and 7 ( Figs. 1a and 3a) . This region corresponds structurally to the PRSbinding sites on other EVH1 domains ( Fig. 1a-e) . This region of EVH1 domains forms a hydrophobic platform that interacts with proteins containing PRSs in actin cytoskeleton and postsynaptic signaling pathways 33 . Thus, the conserved patch 1 of Dcp1p may be a PRS-binding site. Consistent with this conclusion, the N-terminal domain of hDcp1a/SMIF has been found to interact specifically with the proline-rich region (residues 275-308) of SMAD4 so that hDcp1a/SMIF can function as a coactivator in TGFβ signaling 27 . Also consistent with a functional role for conserved patch 1, alanine-scanning mutagenesis has shown that three mutations in this patch, W56A, Y47A and W204A, cause a partial loss-of-function phenotype in vivo 34 .
To probe the function of this region biochemically, we constructed a series of mutations in this region and assayed Dcp1p function using a system where Dcp1p is coexpressed in Escherichia coli with the N-terminal portion of Dcp2p (residues 1-300) 21 . This system allowed us to assess simultaneously whether Dcp2p copurified with the mutant Dcp1 proteins and whether the mutant Dcp1 proteins enhanced the activity of the copurified Dcp2p. The mutations we tested include single and multiple amino acid changes of the conserved residues in this region to alanine. None of these mutations substantially reduced the amount of Dcp2p that copurified with Dcp1p relative to wild-type Dcp1p (Fig. 4a) . The finding that Dcp2p copurified with the mutants indicates that patch 1 is not absolutely required for Dcp1p-Dcp2p binding.
To determine whether these mutations caused a biochemical defect in the Dcp1p-Dcp2p complex, we assayed the decapping activity of Dcp2p copurified with the mutant proteins in vitro in the absence of manganese, a condition under which yeast Dcp2p is dependent on Dcp1p for measurable activity 21 (C.J.D. and R.P., unpublished data). In general, most of the mutations in patch 1, including a triple mutant (L46A Y47A K58A), did not substantially affect the decapping activity of the Dcp1p-Dcp2p complex (Fig. 4b) . Changing Trp56 to alanine, alone or in combination with the Y47A or K58A mutations, did however reduce decapping activity (Fig. 4b) . The reduction in decapping in these mutants is most likely due to the W56A mutation, because Y47A or K58A mutation alone or in combination with mutations other than W56A did not reduce decapping. The effect of the W56A mutation on decapping suggests that the conserved patch 1 affects some intrinsic function of Dcp1p. Alternatively, because Trp56 is absolutely conserved in all EVH1 folds (Fig. 2) and mutation of the corresponding residue (Trp23) in the Mena EVH1 protein alters its from Arabidopsis thaliana were aligned with ClustalW 49 . The alignment of the Mena EVH1 domain sequence is based on its structural similarity with Dcp1p. The secondary structural elements were assigned from the X-ray structure of Dcp1p. Invariant residues are red. structure 39 , Trp56 may have some structural role in Dcp1p. Given that most of the mutations in patch 1 did not affect decapping, one possible function of patch 1 is to enhance some biochemical properties of the enzyme not assessed in our assays. Alternatively, the lack of a strong biochemical phenotype for such marked changes in this conserved surface of the protein suggests that this surface may have a role in contacting regulatory proteins not present in our purified system. Conserved patch 2 is located on a concave surface directly opposite the putative PRS-binding site formed by the N-terminal 3 10 -helix and β-strands 1-4 (Figs. 1a and 3b) . Structurally, this region is analogous to the hotspot of disease mutations found in the N-WASP EVH1 domain 32 and to the region where residues 178-181 of Ran interact with the RanBP EVH1 domain 30 (Fig. 1d,e) . In Dcp1p, a highly conserved cluster of two charged residues, Arg70 and Asp31, and three hydrophobic residues, Tyr68, Pro32 and Ile34, is located in this region (Figs. 1a and 3b) . In support of this region being functionally important for Dcp1p, mutation of Arg70 or Asp31 to alanine inhibits decapping in vivo and leads to an inhibition of the decapping activity purified from yeast cells 34 .
To study the function of patch 2 in more detail, we constructed a series of mutations in this region and purified them from E. coli coexpressing Dcp2p 21 . We tested two alleles with mutations in the charged residues in this region, R29A D31A double mutant and R70A, as well as an allele in which two of the conserved uncharged residues in this region were mutated (P32A I34A). All the mutant Dcp1 proteins copurified with approximately equal amounts of Dcp2p relative to wild-type Dcp1p (Fig. 4c) . This suggests that this region is not required for Dcp1p and Dcp2p to interact, although it could affect the strength of the Dcp1p-Dcp2p interaction.
The mutations of the charged residues in this region caused strong defects in the decapping activity of purified Dcp1p-Dcp2p (Fig. 4d) . Similarly, changing the two hydrophobic residues in this patch led to a partial defect in decapping activity. These results indicate that patch 2 is required for the function of the decapping enzyme Dcp1p-Dcp2p. In addition, because Dcp2p still copurified with these point mutants, these results indicate that at least one function of this region is independent of its role as a binding site for Dcp2p. In this regard, possible functions for patch 2 would include directly binding substrate, assisting in Mg 2+ coordination, or promoting an activating conformational change in Dcp2p.
The defects in decapping caused by mutations in patches 1 and 2 observed in the coexpression system were examined by reconstituting the decapping enzyme with Dcp1p (either wild-type or mutant proteins) and Dcp2p that had been expressed and purified separately. The results are consistent with the coexpression data (see Supplementary  Fig. 1 online) .
A hydrophobic patch is critical for decapping
Mapping of the side chains of hydrophobic residues on the molecular surface of Dcp1p reveals that a large hydrophobic patch is located close to patches 1 and 2 (Fig. 3c) . This hydrophobic patch is predicted to be conserved between yeast and human Dcp1 proteins, as the structure models of human Dcp1a and Dcp1b have similar surface properties (data not shown). The distance from the hydrophobic patch to patch 1 is about three to four residues, consistent with the finding that the two aromatic residues (Tyr301 and Trp302) from the PRS-containing peptide (residues 275-308) of SMAD4 that are essential for hDcp1a binding are four residues away from the PRS 27 . Notably, in the Dcp1p crystal lattice, Val168 and Phe169 from symmetry-related molecules bind to this region through hydrophobic interactions, suggesting that this region indeed is a hydrophobic groove and is possibly involved in binding Dcp2p or other factors.
To examine the role of the hydrophobic patch in Dcp2p binding and decapping, we constructed a quadruple mutant in which Leu37, Leu38, Leu217 and Leu221 were all mutated to alanine. The quadruple mutant was coexpressed with Dcp2p in E. coli and purified. Approximately equal amounts of Dcp2p copurified with the mutant protein as with the wild-type Dcp1 protein (Fig. 4e) . This result suggests that this hydrophobic surface is not absolutely required for Dcp1p to interact with Dcp2p. However, it is still possible that the hydrophobic surface affects the strength of the interaction. Although the L37A L38A L217A L221A mutation did not substantially affect Dcp2p binding, it did cause a strong defect in decapping (Fig. 4f) indicating that this surface is required for Dcp1p to enhance decapping. Given the closeness of the hydrophobic patch to patch 2 and the fact that both patches are required for Dcp1p function, these two features of the protein may function together to promote decapping by Dcp2p. Figure 1a. (c) Molecular surfaces of Dcp1p colored according to residue property, with hydrophobic residues magenta and other residues gray. The hydrophobic patch is marked by a black circle and residues forming the hydrophobic patch on Dcp1p surface are labeled, with conserved residues blue and variant residues black. Figures were produced using GRASP 50 .
DISCUSSION
The crystal structure of yeast Dcp1p presented here resembles the structures of EVH1 domains. EVH1 domains can be divided into three general classes based on their target PRS ligands 35 . All previously characterized EVH1 domains use a highly conserved cluster of three surface-exposed aromatic residues (Tyr16, Trp23 and Phe77; Mena numbering) to recognize their target PRS ligands with remarkably low affinity but high specificity 40 .
Sequence comparison of all the Dcp1 proteins revealed that four out of five conserved aromatic residues, namely Tyr47, Trp49, Trp56 and Trp204, are clustered in the putative PRS-binding site, with the fifth, Tyr68, located in the conserved patch 2 (Figs. 2 and 3a,b) .
Comparison of the putative PRS-binding site of Dcp1p with those of other EVH1 domains revealed some similarities and marked differences as well (Fig. 5a-c) . In Dcp1p, the potential PRS-binding site is lined with conserved aromatic residues including Trp49 (which is a phenylalanine in all other eukaryotic Dcp1 proteins), Trp56, Leu190 (which is a phenylalanine in all other eukaryotic Dcp1 proteins), Tyr47 and Trp204. Specifically, beginning at the upper right of the pocket, Trp49 in Dcp1p is analogous to Tyr16 in Mena, but Wasp and Homer lack an aromatic residue at this position. The next aromatic residue, Trp56, is structurally invariant in all EVH1 domains, corresponding to Trp23 in Mena, Trp24 in Homer and Trp54 in Wasp. Next comes a pair of hydrophobic residues in Dcp1p, Leu190 and Tyr47. Tyr47 matches well with Tyr46 of the EVH1 domain of N-WASP and Phe14 of the Homer EVH1 domain, but this aromatic residue is not present in Mena. Leu190 in Dcp1p corresponds to Phe77 in Mena, Phe104 in N-WASP, and Phe74 in Homer. Notably, this position does show additional variability, as it corresponds to Ser109 in RanBP, although the ligand of this site is not proline-rich. A unique feature of the Dcp1p pocket is Trp204, an invariant residue in all the Dcp1 proteins, that extends the hydrophobic surface, but has no aromatic counterpart in other classes of EVH1 domains. The unique structural arrangement of these key aromatic residues (Tyr47, Trp49, Trp56 and Trp204) in Dcp1p suggests that Dcp1p may have a specificity distinct from that of other EVH1 domains toward the PRS-containing ligands. Based on these comparisons, we suggest that the binding pocket for PRS ligands of EVH1 domains consists of the surface of hydrophobic and aromatic residues and can be substantially extended, as in Dcp1p (five conserved positions), or quite short, as in Mena or Homer, which both have a different set of three of these conserved positions.
Notably, the conserved patch 2 on Dcp1p corresponds to the hotspot of disease mutations in the EVH1 domain of N-WASP (Fig. 5d) . The hotspot of disease mutations in N-WASP includes the most frequently mutated residue Arg76 and other surface residues that flank Arg76, including Leu31, Thr37, Ser40, Cys63 and Phe74 (ref. 32 ). This region has been speculated to be involved in WIP peptide binding to N-WASP based on the NMR structure, but exactly how WIP peptide interacts with the mutational hotspot centered around Arg76 is unknown 32 . Thus, the functional role of residues located at the hotspot of disease mutations of N-WASP remains elusive. The observation that the corresponding region of Dcp1p is critical for function in vivo and in vitro indicates that this surface is functionally important in multiple EVH1 domains 34 (see above) . Given the functional importance of this region in two members of the class III family of EVH1 domains, we suggest that the surface corresponding to patch 2 in Dcp1p is probably a critical region for the function of class III EVH1 domains. This region either could function to enhance the binding of ligands in the PRS site, as in WASP and RanBP1, or may interact with ligands distinct from those in the PRS-binding pocket and thereby allow EVH1 domains to link proteins together.
In conclusion, Dcp1p has two structurally conserved sites. One of these sites corresponds to the PRS-binding sites of other EVH1 proteins and may belong to a novel class of EVH1 domains. The second conserved site is required for decapping by the Dcp1p-Dcp2p complex. This site is structurally analogous to the hotspot of disease mutations in the EVH1 domain of N-WASP. This similarity suggests that certain classes of EVH1 domains may bear a second functionally key region in addition to their PRS-binding sites. Our work provides a starting point for further crystallographic, biochemical and genetic studies of Dcp1 proteins to elucidate their role in mRNA decapping as well as understanding the role of this second functional region of EVH1 domains.
METHODS
Cloning, expression and purification. The full-length Dcp1 gene was cloned from S. cerevisiae genomic DNA by PCR amplification using oligonucleotides Dcp1-F (GCGCGGATCCATGACCGGAGCAGCAACTGC) and Dcp1-R (GCGCCTCGAGTTAAGCAAAAGAATCTTTTGGCTC). The DNA fragment was digested with restriction enzymes BamHI and XhoI and ligated into the same site of pGEX-6p-1 (Pharmacia Biotech) to generate pGEX-dcp1. The construct was verified by DNA sequencing. E. coli strain BL21(DE3) star (Novagen) harboring the pGEX-dcp1 was grown in 4 L of LB medium at 37°C and induced with 0.1 mM IPTG at 30 °C for 3 h upon reaching log phase. The cells were harvested by centrifugation, resuspended in lysis buffer (20 mM Tris-HCl, pH 7.6, 500 mM NaCl, 0.1 mM PMSF, 2 mM benzamidine, 2 mM DTT), and disrupted by sonication. Clarified cell lysate was applied to a glutathione Sepharose 4B column (Amersham). The eluted fractions were subjected to PreScission protease (Amersham) digestion at 4 °C overnight to cleave the GST tag. The desalted fractions were further purified by a second glutathione Sepharose 4B column and gel filtration (HiLoad 20/60 Superdex75, Amersham) in the ÄKTA FPLC system (Amersham). Monomeric Dcp1 protein was purified to homogeneity and concentrated to 12 mg ml -1 in storage buffer (20 mM Tris-HCl, pH 7.6, 100 mM NaCl, 2 mM MgCl 2 and 2 mM DTT). Protein identity was confirmed by Edman degradation N-terminal sequencing and mass spectrometry molecular mass determination. SeMet-substituted Dcp1p was purified in the same way except the DTT concentration was 10 mM.
Crystallization and data collection. Structure determination and refinement. Four Se sites were found using SHELXD 42 . Refinement of the heavy-atom sites and phase estimation were done using SHARP 43 . The resulting phases were further improved by solvent flattening using SOLOMON 44 . Model building was done using O 45 .
Crystallographic refinement was carried out with CNS 46 . σA-weighted 2F o -F c and F o -F c maps were used to guide rebuilding of the model using O throughout the refinement. Water molecules were automatically included with CNS and manually edited with electron densities. The final refinement statistics are summarized in Table 1 .
Modeling of hDcp1a and hDcp1b. Dcp1p structure was used as a template to model the N-terminal domains of hDcp1a and hDcp1b with O 45 . The peptide gaps resulting from the two insertions in Dcp1p sequences were fixed by comparing the models with the Mena EVH1 structure. The resulting models were subjected to energy minimization using CNS 46 .
Biochemical analysis of mutant Dcp1 proteins. The mutations in Dcp1p were introduced into pRP1071, a plasmid designed to express both Flag-tagged fulllength Dcp1p and a His 6 -tagged N-terminal 30-kDa fragment of Dcp2p in E. coli 21 . The R29A D31A, W56A Y47A W204, and R70A alleles were introduced by PCR-amplifying the mutant allele from the corresponding yeast expression plasmid containing the mutant DCP1 gene 34 using oligonucleotides oRP1162 (GGAGATATACATATGGACTACAAGGACGACGATGACAAGATG ACCGGAGCAGCAACTG) and oRP1163 (CGCGGATCCTCAAGCAAAAG AATCTTTTGGCT), which introduced the Flag-tag at the N terminus of Dcp1p and a BamHI site just 3′ of the stop codon. The resulting PCR products were amplified with oRP1161 (CGGTTTCCCTCTAGAAATAATTTTGTTTAAC TTTAAGAAGGAGATATACATATGGACTACAAGG) and oRP1163 to introduce a ribosome-binding site and XbaI site 5′ of the Flag-tag. The resulting PCR products were cut with XbaI and BamHI and used to replace the wild-type Dcp1 gene in pRP1071. The additional mutant alleles were created using the QuikChange site-directed mutagenesis kit (Stratagene). Y47A W56A was generated using the W56A plasmid, oRP1164 (CACACACCACATGCGT CACTGGCCAAATGGGACTTCAAGAAGGATGAAGC) and oRP1165 (GCTT CATCCTTCTTGAAGTCCCATTTGGCCAGTGACGCATGTGGTGTGTG). L46AY47A was generated using the Y47A plasmid, oRP1166 (CACACACCA CATGCGTCAGCGGCCAAATGGGACTTCAAG) and oRP1167 (CTTGAAG TCCCATTTGGCCGCTGACGCATGTGGTGTGTG). W56A K58A was generated using the W56A plasmid, oRP1168 (GGACTTCAAGAAGGATGAAGC TAATGCACTAGAATATCAAGGTGTTTTGG) and oRP1169 (CCAAAACAC CTTGATATTCTAGTGCATTAGCTTCATCCTTCTTGAAGTCC). L46A Y47A K58A was generated using the L46A Y47A plasmid, oRP1174 (CACACAC CAATGCGTCAGCGGCCAAATGGGACTTCAAGAAGGACGAATGGAATGC CCTAGAATATCAAGGTGTTTTGG) and oRP1175 (CCAAAACACCTTGAT ATTCTAGGGCATTCCATTCGTCCTTCTTGAAGTCCCATTTGGCCGCT GACGCATGTGGTGTGTG). P32A I34A was generated using pRP1071, oRP1178 (GAATTTCAACGTTATTGGGAGATACGATGCAAAAGCAAAGCA ACTACTTTTTCACACACC) and oRP1179 (GGTGTGTGAAAAAGTAGTT GCTTTGCTTTTGCATCGTATCTCCCAATAACGTTGAAATTC). L37A L38A L217A L221A was generated in two steps. First, pRP1071 was used as the template with oRP1204 (CGTTATTGGGAGATACGATCCAAAAATAAAGCAAGC AGCTTTTCACACACCACATGCGTCACTG) and oRP1205 (CAGTGACGC ATGTGGTGTGTGAAAAGCTGCTTGCTTTATTTTTGGATCGTATCTCCC AATAACG) to introduce L37A L38A. Then, the resulting mutant plasmid was used as the template with oRP1206 (CAGTCAGTGATAGACAAAATATCTACG AAGCAATAAAATATGCTCTGGAAAATGAGCCAAAAGATTC) and oRP1207 (GAATCTTTTGGCTCATTTTCCAGAGCATATTTTATTGCTTCGTAGATATT TTGTCTATCACTGACTG) to introduce L217A L221A. All mutant alleles were verified by sequencing. The wild-type and mutant Flag-tagged Dcp1 and His 6 -tagged Dcp2 proteins were coexpressed in DH5α and purified as described 21 . Western blot analysis against Dcp2p was carried out using standard protocols with monoclonal antiHis (Novagen).
Cap-labeled 99 nucleotide MFA2 mRNA substrate was prepared as described 47 . Decapping reactions were done in 20-µl volumes containing 50 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 50 mM NH 4 Cl, 1 mM DTT, 10 units RNasin (Promega), 10 fmol substrate RNA and 0.12-1.2 µg total protein. After incubation at 30°C for 15 min, a 2-µl aliquot was removed and reaction was stopped in this aliquot using 1 µl of 0.5 M EDTA on ice. Products were separated on a PEI cellulose thin layer chromatography plate (Selecto) in 0.75 M LiCl 2 and detected with a phosphorimager (Molecular Dynamics). 
